CHRISTINA LYNN ROLAND to Biomarkers, Tumor
This is a "connection" page, showing publications CHRISTINA LYNN ROLAND has written about Biomarkers, Tumor.
Connection Strength
0.480
-
Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma. JAMA Surg. 2016 Apr; 151(4):347-54.
Score: 0.138
-
Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma. Ann Surg Oncol. 2016 07; 23(7):2220-8.
Score: 0.137
-
Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1. Mol Carcinog. 2025 Jan; 64(1):44-56.
Score: 0.063
-
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. Clin Cancer Res. 2020 03 15; 26(6):1258-1266.
Score: 0.045
-
Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study. Melanoma Res. 2015 Aug; 25(4):335-41.
Score: 0.033
-
Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer. PLoS One. 2009 Nov 03; 4(11):e7669.
Score: 0.022
-
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. Mol Cancer Ther. 2024 Jul 02; 23(7):1057-1065.
Score: 0.015
-
The Landscape of Immunotherapy for Retroperitoneal Sarcoma. Curr Oncol. 2023 02 09; 30(2):2144-2158.
Score: 0.014
-
Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state. Acta Neuropathol. 2021 09; 142(3):565-590.
Score: 0.012